US2019209632A1PendingUtilityA1
Pharmaceutical Composition for Preventing and Treating Alpha Herpes Virus Infection, Containing, As Active Ingredient, Elaeocarpus Sylvestris Extract or Fraction Thereof
Est. expirySep 9, 2036(~10.1 yrs left)· nominal 20-yr term from priority
A61K 2236/33A61K 31/365A61K 31/235A23L 33/105A23V 2002/00A61P 31/22A61K 36/185
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a pharmaceutical composition for preventing or treating alpha-herpesvirus infection comprising an Elaeocarpus sylvestris extract or a fraction thereof as an active ingredient, and can effectively prevent, treat or alleviate an alpha-herpesvirus and diseases caused thereby, such as herpes, encephalitis, genital herpes, chicken pox, or herpes zoster.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical composition for preventing and treating alpha-herpesvirus infection comprising an Elaeocarpus sylvestris extract or a fraction thereof as an active ingredient.
2 . The pharmaceutical composition of claim 1 , wherein the Elaeocarpus sylvestris extract is obtained by extraction with water, a lower alcohol having 1 to 4 carbon atoms, or a mixture thereof.
3 . The pharmaceutical composition of claim 2 , wherein the Elaeocarpus sylvestris extract is a 50% ethanol extract.
4 . The pharmaceutical composition of claim 1 , wherein the alpha-herpesvirus is one or more viruses selected from among varicella-zoster virus (VZV), herpes simplex virus-1 (HSV-1) and herpes simplex virus-2 (HSV-2).
5 . The pharmaceutical composition of claim 1 , wherein the alpha-herpesvirus infection is any one or more selected from among herpes, genital herpes, chickenpox, and herpes zoster.
6 . The pharmaceutical composition of claim 1 , wherein the Elaeocarpus sylvestris extract comprises any one or more selected from the group consisting of methyl gallate, geraniin and casuarictin.
7 . A pharmaceutical formulation for preventing and treating alpha-herpesvirus infection comprising an Elaeocarpus sylvestris extract or a fraction thereof as an active ingredient.
8 . A health food for preventing and alleviating alpha-herpesvirus infection comprising an Elaeocarpus sylvestris extract or a fraction thereof as an active ingredient.
9 . The health food of claim 8 , wherein the Elaeocarpus sylvestris extract is obtained by extraction with water, a lower alcohol having 1 to 4 carbon atoms, or a mixture thereof.
10 . The health food of claim 8 , wherein the alpha-herpesvirus is one or more viruses selected from among varicella-zoster virus (VZV), herpes simplex virus-1 (HSV-1) and herpes simplex virus-2 (HSV-2).
11 . The health food of claim 8 , wherein the alpha-herpesvirus infection is one or more selected from among herpes, encephalitis, genital herpes, chickenpox, and herpes zoster.
12 . The health food of claim 8 , wherein the Elaeocarpus sylvestris extract comprises any one or more selected from the group consisting of methyl gallate, geraniin and casuarictin.Join the waitlist — get patent alerts
Track US2019209632A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.